Enrol before 6 October to save 20%
Discount has been applied to the price above. VAT, if applicable, will be added.
£316.00
2-day live online training
Be aware of the assays needed to assess pharmacokinetics, immunogenicity and potency for cell and gene therapies
Discount has been applied to the price above. VAT, if applicable, will be added.
A growing number of cell and gene therapies or ATMPs are entering development. Like other therapeutics they need to be clinically developed with data gathered on pharmacokinetics, immunogenicity and potency to satisfy regulatory safety expectations. However, unlike biopharmaceuticals, ATMPs are a very different challenge and a new way of thinking is required.
This training course will provide you with a deep dive insight into how cell and gene therapy products are clinically developed and manufactured. Once completed you will be aware of the types of assays needed to assess pharmacokinetics, immunogenicity and potency. You will also examine the regulatory expectations around assay validation.
You can view the agenda below or if you would like to receive a pdf version with all the course information, please complete the form below.
Learn more about the course by toggling through the tabs below (trainer, who should attend?)
Want to train your team, department or whole organisation? This course can be developed into on-demand e-learning and hosted by Educo Life Sciences or on your own LMS platform.
Email [email protected] for more information.
We can customise this course to meet the requirements of your organisation, delivered as a classroom and/or online course.
For more information you can email us at [email protected] or call +44 (0) 203 111 7357.
Complete our contact form by following the link. Get in touch.
* | • This course is delivered online |
---|